Published in Blood Weekly, April 13th, 2000
A major focus of this collaboration is to further develop and optimize proprietary systems for the delivery of SMCs into human stem cells and other more differentiated cell types. Gil Van Bokkelen, PhD, Athersys, discussed this collaboration and describe the multiple applications of RAGE (Random Activation of Gene Expression) technology at the BIO 2000 Conference, held in Boston, Massachusetts, during March 2000.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.